The need of a multicomponent guiding approach to personalize clopidogrel treatment C Valeria et al, Pharmacogenomics Journal, October 9, 2020

Hot Topics of the Day|PHGKB

 Pharmacogenomics

The need of a multicomponent guiding approach to personalize clopidogrel treatment
C Valeria et al, Pharmacogenomics Journal, October 9, 2020

A systematic review of the controversies about the use of CYP2C19 pharmacogenetics and platelet function testing to personalize clopidogrel treatment. We assess literature with our findings concerning patients eligible for vascular surgery and treated with clopidogrel, in whom we used a combined management based on the CYP2C19 and ABCB1 pharmacogenetic testing.